Latest news with #preventiveCare
Forbes
24-05-2025
- Health
- Forbes
Making Mammograms Automatic – Unintended Consequences Of A Behavioral Economic Intervention
SEVILLE ANDALUSIA, SPAIN - OCTOBER 19: A lady with the help of a nurse gets a mammogram. (Photo By ... More Eduardo Briones/Europa Press via Getty Images) The experiment was simple. A group of behaviorally-minded researchers tested whether patients are more likely to receive mammograms when those tests are automatically scheduled (meaning they can opt out if they want) versus when they have to opt in for the tests. The researchers predicted that people who have to opt out of the test will be much more likely to receive it. Lots of research shows that when you turn a behavior into a default, things are more likely to happen. Automatically max people's retirement contributions and people are more likely to…maximize their retirement contributions (even though they could opt out of this option). Make the James Bond theme song the default ring tone, and lots of people will hear that theme song when their phone rings, the default option becoming their 'choice.' Inertia is a powerful force. Add to that the importance of mammography, and automatically scheduling mammograms should significantly increase use of that test, a great outcome with no apparent downside. Except that's not what happened. Here's why. In the study, which was led by Leah Marcotte a physician at the University of Washington, the research team randomized over 800 women mammography into one of two groups: To my surprise, the opt out intervention did not work as predicted. It did not increase the number of women receiving mammograms, with 15% of women receiving mammograms regardless of whether they were in the opt out or the opt in group. You might think 'no harm, no foul.,' that the opt out intervention did not increase screening but did not reduce it either. But the intervention backfired in one meaningful way – it created lots of work for healthcare providers handling mammography appointments. In the opt in group, 5% of women scheduled mammograms and then canceled their appointments; in the opt out group, the cancellation rate was 24%. This well conducted study is hardly a death knell for opt out interventions, which have proven to work in many healthcare and nonhealthcare settings. Instead, it is a reminder that a host of other factors – populations, organizations, finances – potentially alter the impact of behavioral interventions. We should not assume we know how behavioral interventions will influence the people we are trying to help. Instead, we should expose those interventions to rigorous tests. Kudos to to Marcotte and her team for doing so, and for reminding us to expose behavioral interventions to the rigors of science.
Yahoo
22-05-2025
- Business
- Yahoo
Human Papilloma Virus Testing Market Trends Analysis Report 2025-2030: Educational Efforts and At-Home HPV Kits Propel Testing Uptake and Dive Market Expansion Through Accessibility
The Human Papilloma Virus Testing Market is set to grow from USD 1.76 Billion in 2024 to USD 3.72 Billion by 2030, driven by a 13.60% CAGR. Rising screenings, at-home testing kits, and technological breakthroughs are key growth drivers. The comprehensive report covers market segmentation, trends, and forecasts till 2030. Human Papilloma Virus Testing Market Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Human Papilloma Virus Testing Market Size, Share, & Trends Analysis Report by Application (Cervical Cancer Screening, Vaginal Cancer Screening), Product, Technology, End Use, Region, with Growth Forecasts, 2025-2030" report has been added to Human Papilloma Virus Testing Market was valued at USD 1.76 Billion in 2024, and is projected to reach USD 3.72 Billion by 2030, rising at a CAGR of 13.60%. Educational initiatives and public health campaigns encourage people to get tested regularly, leading to higher screening rates. The adoption of at-home testing kits is further driving market expansion. These kits provide a convenient, private, and accessible method for individuals to test for HPV, empowering users to manage their health more proactively. The combination of heightened awareness and the availability of at-home testing is significantly boosting market demand for preventive healthcare is projected to fuel the growth of the HPV testing industry, with more individuals seeking early detection to avoid HPV-related cancers. This shift toward proactive health measures encourages routine HPV screenings, especially for women over 30. Technological advancements in testing methods, including PCR-based and next-generation sequencing, are further enhancing the accuracy and efficiency of HPV tests. These innovations make testing more accessible, reliable, and cost-effective, thus driving market expansion by improving the overall patient experience and encouraging broader adoption of HPV testing solutions. Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report Attribute Details No. of Pages 110 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $1.76 Billion Forecasted Market Value (USD) by 2030 $3.72 Billion Compound Annual Growth Rate 13.6% Regions Covered Global Human Papilloma Virus (HPV) Testing Market Variables, Trends, & Scope Market Lineage Outlook Parent Market Outlook Related/Ancillary Market Outlook Market Dynamics Market Driver Analysis Market Restraint Analysis Human Papilloma Virus (HPV) Testing Market Analysis Tools Industry Analysis - Porter's Five Forces Analysis PESTLE Analysis Global Human Papilloma Virus Testing Market Report: SegmentationApplication Outlook (Revenue, USD Million, 2018-2030) Cervical Cancer Screening Vaginal Cancer Screening Product Outlook (Revenue, USD Million, 2018-2030) Instruments Consumables Services Technology Outlook (Revenue, USD Million, 2018-2030) PCR Immunodiagnostics Others End Use Outlook (Revenue, USD Million, 2018-2030) Hospitals & Clinics Laboratories Others Regional Outlook (Revenue, USD Million, 2018-2030) North America Europe Asia-Pacific Latin America Middle East & Africa Companies Featured Abbott Biomedical Diagnostics bioMerieux CanAg Diagnostics (Beijing) Co., Ltd. Cemines Bio-Rad Laboratories, Inc. Epigenomics AG Fujirebio Guided Therapeutics, Inc. Oncolab Hologic, Inc. Qiagen Radiant Pharmaceuticals Limited F. Hoffmann-La Roche Ltd Siemens Healthineers AG For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Human Papilloma Virus Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Arab News
08-05-2025
- Health
- Arab News
Meena Health launches Riyadh's first occupational health center
Meena Health has officially opened the Meena Occupational Health Center in Riyadh — the first dedicated facility in the capital to provide specialized healthcare services focused exclusively on occupational health and safety. The launch marks a major milestone in advancing preventive care for the Kingdom's workforce and aligns with broader national efforts to foster healthier, safer work environments. Coinciding with the center's inauguration, Meena Health also signed a series of strategic agreements and MoUs, reinforcing its leadership position in the field and its growing role within Saudi Arabia's evolving healthcare landscape. The Meena Occupational Health Center offers an integrated suite of services that includes pre-employment medical evaluations, periodic employee health checkups, and specialized assessments for high-risk industries such as aviation and maritime. The facility also provides rehabilitation services and disability assessments, all designed to foster a culture of prevention, support regulatory compliance, and elevate occupational health standards nationwide. To bring healthcare closer to the workplace, Meena Health signed a cooperation agreement to establish on-site clinics at company locations, allowing employees to access care conveniently within their work environments. Additionally, a new MoU will facilitate the delivery of medical fitness examinations for both new and existing employees, enhancing workforce readiness and reducing occupational health risks. The National Council for Occupational Safety and Health has designated Meena Occupational Health Center as a center of excellence. This acknowledgment highlights the center's role in preventive occupational healthcare and its contribution to building safe, sustainable workplaces in line with global best practices. Moreover, Meena Academy signed an academic partnership with the National Institute for Occupational Safety and Health. The collaboration will focus on developing national talent through specialized training and education programs tailored to the occupational health sector. Dr. Suleiman Al-Towayan, CEO of Meena Health, emphasized the significance of this launch as a transformative step toward improving employee well-being across Saudi Arabia. 'Opening Riyadh's first specialized occupational health center sets a new benchmark for workplace health and safety in the Kingdom.' he said. 'It reflects our commitment to advancing the goals of Vision 2030 by promoting a proactive approach to healthcare through early screening, home care, telemedicine, and now, specialized occupational services.' He added: 'At Meena Health, we believe that prevention is better than cure. This belief drives everything we do.' With the launch of its first specialized occupational health center in Riyadh, Meena Health is poised to play a leading role in shaping the future of workplace wellness in Saudi Arabia. The company remains committed to advancing preventive healthcare, strengthening strategic partnerships, and supporting the Kingdom's journey toward a more resilient and healthier workforce.
